Skip to Main Content

Paper Details

Neutralizing Anti-Granulocyte Macrophage-Colony Stimulating Factor Autoantibodies Recognize Post-Translational Glycosylations on Granulocyte Macrophage-Colony Stimulating Factor Years Before Diagnosis and Predict Complicated Crohn's Disease.
Gastroenterology
19
2022
Anti-GMAbs, Anti-Granulocyte Macrophage-Colony Stimulating Factor Autoantibodies, Anti-granulocyte macrophage-colony stimulating factor autoantibodies, CD, CD mucosa, Complicated Crohn's Disease, GM-CSF, Granulocyte Macrophage-Colony Stimulating Factor, aGMAbs, epitopes, granulocyte macrophage-colony stimulating factor, group 1 innate lymphoid cells, ileal Crohn's disease, innate lymphoid cell, myeloid cell, patients
Author NameAffiliation
Romain RemarkPrecision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York Innate Pharma
Francesca PetraliaIcahn Institute for Data Science and Genomic Technology, Icahn School of Medicine at Mount Sinai
Joseph A MurrayMayo Clinic
Adeeb RahmanPrecision Immunology Institute, Icahn School of Medicine at Mount Sinai
Judy H ChoCharles Bronfman Institute for Personalized Medicine, Icahn School of Medicine at Mount Sinai
Miriam MeradPrecision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York Tisch Cancer Institute
Miriam MeradPrecision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York Tisch Cancer Institute
Jean-Frederic ColombelPrecision Immunology Institute, Icahn School of Medicine at Mount Sinai
Sacha GnjaticPrecision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York Tisch Cancer Institute
Sacha GnjaticPrecision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York Tisch Cancer Institute
  • 1 - 10

Datasets

Release 1.2